In Friday’s Wall Street session, Aura Biosciences Inc (NASDAQ:AURA) shares traded at $7.95, up 0.13% from the previous session.
AURA stock price is now -2.18% away from the 50-day moving average and -6.23% away from the 200-day moving average. The market capitalization of the company currently stands at $397.10M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $21, H.C. Wainwright recently initiated with Buy rating for Aura Biosciences Inc (NASDAQ: AURA)., while ‘BTIG Research’ rates the stock as ‘Buy’
In other news, de los Pinos Elisabet, Officer bought 15,955 shares of the company’s stock on Jan 21 ’25. The stock was bought for $122,381 at an average price of $7.67. An SEC document containing details of the transaction can be found on the SEC’s website. On Jan 21 ’25, Officer Elazzouzi Amy bought 1,001 shares of the business’s stock. A total of $7,679 was incurred on buying the stock at an average price of $7.67. A total of 11.10% of the company’s stock is owned by insiders.
During the past 12 months, Aura Biosciences Inc has had a low of $6.63 and a high of $12.38. As of last week, the company has a debt-to-equity ratio of 0.11, a current ratio of 12.47, and a quick ratio of 12.47. The fifty day moving average price for AURA is $8.1268 and a two-hundred day moving average price translates $8.477875 for the stock.
The latest earnings results from Aura Biosciences Inc (NASDAQ: AURA) was released for 2024-09-30. The company reported revenue of $23.23 million for the quarter, compared to $20.49 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 13.39 percent.
